On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Beijing Biocytogen (China)

InstitutionResearch output, impact & collaborations

Beijing Biocytogen (China) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Beijing Biocytogen (China)?

ScholarIQrecord summary

Beijing Biocytogen (China) is a research organisation in Beijing, CN. OpenAlex records 1,423 works and 60,070 citations for it. 964 researchers list it as their most recent affiliation.

How many works does Beijing Biocytogen (China) have?

ScholarIQindexed works

Beijing Biocytogen (China) has 1,423 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Beijing Biocytogen (China) →

How many citations does Beijing Biocytogen (China) have?

ScholarIQcitation count

Beijing Biocytogen (China) has 60,070 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Beijing Biocytogen (China) →

How many researchers are at Beijing Biocytogen (China)?

ScholarIQresearcher count

Beijing Biocytogen (China) has 964 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Beijing Biocytogen (China)?

ScholarIQavg h-index

Beijing Biocytogen (China) has an average h-index of 27 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Beijing Biocytogen (China)?

ScholarIQror

The ROR for Beijing Biocytogen (China) is on the source record.

Open the ROR →

What is the OpenAlex record for Beijing Biocytogen (China)?

ScholarIQopenalex

The OpenAlex for Beijing Biocytogen (China) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Beijing Biocytogen (China)?

ScholarIQtop researchers by citations

Ping Li · SARS-CoV-2 and COVID-19 Research

117 works21,439 citations

What are the most-cited papers on Beijing Biocytogen (China)?

ScholarIQmost cited works

Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation

Ting Gao, Mingdong Hu, Xiaopeng Zhang, Hongzhen Li, Lin Zhu, Hainan Liu, Qincai Dong, Zhang Zhang, Zhongyi Wang, Yong Hu, Yangbo Fu, Yanwen Jin, Kaitong Li, Songtao Zhao, Yongjiu Xiao, Shuping Luo, Lufeng Li, Lingfang Zhao, Junli Liu, Huailong Zhao, Yue Liu, Weihong Yang, Jing Peng, Xiaoyu Chen, Ping Li, Yaoning Liu, Yonghong Xie, Jibo Song, Lu Zhang, Qingjun Ma, Xiuwu Bian, Wei Chen, Xuan Liu, Qing Mao, Cheng Cao

medRxiv. 2020364 CitationsOPEN ACCESS

Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort study

Zhongwei Jia, Yurong Mao, Fujie Zhang, Yuhua Ruan, Ye Ma, Jian Li, Wei Guo, Enwu Liu, Zhihui Dou, Yan Zhao, Lu Wang, Qianqian Li, Peiyan Xie, Houlin Tang, Jing Han, Xia Jin, Juan Xu, Ran Xiong, Decai Zhao, Ping Li, Xia Wang, Liyan Wang, Qianqian Qing, Zhengwei Ding, Ray Y. Chen, Zhongfu Liu, Yiming Shao

The Lancet. 2012159 Citations

How much of the research on Beijing Biocytogen (China) is open access?

ScholarIQopen access share

50%OPEN ACCESS

Gold

Green

50%

Hybrid

Bronze

Closed

50%